£42.60

Humana Bacterial Genomes and Infectious Diseases

Price data updated today

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

Got more expensive overnight. Up £9 in a week — the last 3 spikes settled within a month.

£43 today · was £33 last week · 30-day average £38

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 91 days • 91 data points

Historical
Generating forecast...
£48.06 £31.63 £35.21 £38.80 £42.38 £45.97 £49.55 24 February 2026 18 March 2026 10 April 2026 02 May 2026 25 May 2026

Price Distribution

Price distribution over 91 days • 5 price levels

Days at Price
Current Price
46 days 20 days 13 days 8 days 4 days 0 12 23 35 46 £33 £43 £44 £47 £48 Days at Price

Price Analysis

Most common price: £33 (46 days, 50.5%)

Price range: £33 - £48

Price levels: 5 different prices over 91 days

Description

The first bacterial genome, Haemophilus influenzae, was completely sequenced, annotated, and published in 1995. Today, more than 200 prokaryotic (archaeal and bacterial) genomes have been completed and over 500 prokaryotic genomes are in va- ous stages of completion. Seventeen eukaryotic genomes plus four eukaryotic chro- somes have been completed. The concept of achieving better understanding of an organism through knowledge of the complete genomic sequence was first demonstrated in 1978 when the first bacteriophage genome, X174, was sequenced. Complete genomic sequences of prokaryotes have led to a better understanding of the biology and evolution of the microbes, and, for pathogens, facilitated identification of new vaccine candidates, putative virulence genes, targets for antibiotics, new strategy for rapid diagnosis, and investigation of bacteria–host interactions and disease mec- nisms. Recent increased interest in microbial pathogens and infectious diseases is largely attributed to the re-emergence of infectious diseases like tuberculosis, emergence of new infectious diseases like AIDS and severe acute respiratory syndrome, the problem of an increasing rate of emergence of antibiotic-resistant variants of pathogens, and the fear of bioterrorism. Microbes are highly diverse and abundant in the biosphere. Less than 1% of these morphologically identified microbes can be cultured in vitro using standard techniques and conditions. With such abundance of microbes in nature, we can expect to see new variants and new species evolve and a small number will emerge as pathogens to humans.

Product Specifications

Barcode

No barcode data available